Major Korean companies concentrating on 'aggressive marketing '

To safeguard better position in the local pharmaceutical market influenced by the first round of SDP (separation of dispensing from medical practice) function, the leading Korean drug makers are focusing their 2002 business strategies to aggressive marketing.

According to Yakup Shinmoon, which made direct interviews with CEOs of 24 Korean leading firms, the majority of these companies will e...